4DMT has completed global enrollment for 4FRONT-2
Author: Michael
Boston biotech secures Series A funding to move
Former Verge Genomics is building AI models from
15,000-woman waitlist suggests demand for precis
FDA Breakthrough Therapy Designation for fosigot
New evidence suggests one overlooked saturated f
NeuroSense reported positive biomarker findings f
Generation Lab announced the general availability
VeriSIM Life has entered into a Material Transfer
LyGenesis received a research award from Breakthr